Published in Semin Nephrol on September 01, 2010
OrthoMCL-DB: querying a comprehensive multi-species collection of ortholog groups. Nucleic Acids Res (2006) 11.43
Inparanoid: a comprehensive database of eukaryotic orthologs. Nucleic Acids Res (2005) 9.90
The Zebrafish Information Network: the zebrafish model organism database. Nucleic Acids Res (2006) 7.66
The mouse Gene Expression Database (GXD): updates and enhancements. Nucleic Acids Res (2004) 7.26
FlyBase: genomes by the dozen. Nucleic Acids Res (2006) 6.96
Global analysis of patterns of gene expression during Drosophila embryogenesis. Genome Biol (2007) 6.27
FlyBase: anatomical data, images and queries. Nucleic Acids Res (2006) 6.01
Maximizing mouse cancer models. Nat Rev Cancer (2007) 5.38
FlyBase: integration and improvements to query tools. Nucleic Acids Res (2007) 5.14
GXD: a gene expression database for the laboratory mouse. The Gene Expression Database Group. Nucleic Acids Res (1999) 5.10
The Zebrafish Information Network: the zebrafish model organism database provides expanded support for genotypes and phenotypes. Nucleic Acids Res (2007) 4.30
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2009) 3.74
EMAGE: a spatial database of gene expression patterns during mouse embryo development. Nucleic Acids Res (2006) 3.48
Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev (2007) 3.45
The mouse Gene Expression Database (GXD): 2007 update. Nucleic Acids Res (2006) 3.30
FlyBase : a database for the Drosophila research community. Methods Mol Biol (2008) 3.02
The quest for orthologs: finding the corresponding gene across genomes. Trends Genet (2008) 2.86
Characterization of susceptibility of inbred mouse strains to diabetic nephropathy. Diabetes (2005) 2.67
GUDMAP: the genitourinary developmental molecular anatomy project. J Am Soc Nephrol (2008) 2.45
4DXpress: a database for cross-species expression pattern comparisons. Nucleic Acids Res (2007) 2.38
Impact of genetic background on nephropathy in diabetic mice. Am J Physiol Renal Physiol (2005) 2.29
EMAGE mouse embryo spatial gene expression database: 2010 update. Nucleic Acids Res (2009) 2.16
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes (2008) 2.07
Analysis of Drosophila segmentation network identifies a JNK pathway factor overexpressed in kidney cancer. Science (2009) 1.83
Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol Biol Cell (2003) 1.79
A panoramic view of gene expression in the human kidney. Proc Natl Acad Sci U S A (2003) 1.72
Large-scale identification of genes implicated in kidney glomerulus development and function. EMBO J (2006) 1.69
EMAGE--Edinburgh Mouse Atlas of Gene Expression: 2008 update. Nucleic Acids Res (2007) 1.66
Molecular profiling of diabetic mouse kidney reveals novel genes linked to glomerular disease. Diabetes (2004) 1.58
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humans. J Clin Invest (2009) 1.54
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol (2008) 1.44
Organization of the pronephric kidney revealed by large-scale gene expression mapping. Genome Biol (2008) 1.31
Transcriptomic analyses reveal novel genes with sexually dimorphic expression in the zebrafish gonad and brain. PLoS One (2008) 1.17
Defining human diabetic nephropathy on the molecular level: integration of transcriptomic profiles with biological knowledge. Rev Endocr Metab Disord (2008) 1.16
Renal gene and protein expression signatures for prediction of kidney disease progression. Am J Pathol (2009) 1.15
The glomerular transcriptome and a predicted protein-protein interaction network. J Am Soc Nephrol (2007) 1.07
Gene expression profiling analysis in nephrology: towards molecular definition of renal disease. Clin Exp Nephrol (2006) 1.07
Glomerulus-specific mRNA transcripts and proteins identified through kidney expressed sequence tag database analysis. Kidney Int (2007) 1.05
Cross-species and cross-platform gene expression studies with the Bioconductor-compliant R package 'annotationTools'. BMC Bioinformatics (2008) 1.00
Gene expression profiling of anti-GBM glomerulonephritis model: the role of NF-kappaB in immune complex kidney disease. Kidney Int (2004) 0.96
Comparative gene expression analysis of zebrafish and mammals identifies common regulators in hematopoietic stem cells. Blood (2009) 0.95
Gene expression analysis in renal biopsies. Nephrol Dial Transplant (2004) 0.93
The role of aldosterone blockade in murine lupus nephritis. Arthritis Res Ther (2008) 0.88
Gene expression profiling in the remnant kidney model of wild type and kinin B1 and B2 receptor knockout mice. Kidney Int (2007) 0.88
COMPARE, a multi-organism system for cross-species data comparison and transfer of information. Bioinformatics (2007) 0.85
Gene expression analysis defines the proximal tubule as the compartment for endocytic receptor-mediated uptake in the Xenopus pronephric kidney. Pflugers Arch (2008) 0.84
Gene expression analysis of human renal biopsies: recent developments towards molecular diagnosis of kidney disease. Curr Opin Nephrol Hypertens (2004) 0.83
Serum and urinary biomarker signatures for rapid preclinical in vivo assessment of CDK inhibition as a therapeutic approach for PKD. Cell Cycle (2008) 0.82
Cancer gene discovery in mouse and man. Biochim Biophys Acta (2009) 0.81
Mouse models of diabetic nephropathy. J Am Soc Nephrol (2004) 3.95
Research capacity. Enabling the genomic revolution in Africa. Science (2014) 3.05
Enhanced expression of Janus kinase-signal transducer and activator of transcription pathway members in human diabetic nephropathy. Diabetes (2008) 2.07
Hypotension, lipodystrophy, and insulin resistance in generalized PPARgamma-deficient mice rescued from embryonic lethality. J Clin Invest (2007) 1.85
A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expression. Am J Physiol Cell Physiol (2008) 1.70
From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes (2008) 1.65
Rosiglitazone reduces renal and plasma markers of oxidative injury and reverses urinary metabolite abnormalities in the amelioration of diabetic nephropathy. Am J Physiol Renal Physiol (2008) 1.44
Enhanced glycogen synthase kinase-3beta activity mediates hypoxia-induced apoptosis of vascular smooth muscle cells and is prevented by glucose transport and metabolism. J Biol Chem (2002) 1.43
Identification of cross-species shared transcriptional networks of diabetic nephropathy in human and mouse glomeruli. Diabetes (2012) 1.39
Reduction in podocyte density as a pathologic feature in early diabetic nephropathy in rodents: prevention by lipoic acid treatment. BMC Nephrol (2006) 1.34
Glucose transporter-1-deficient mice exhibit impaired development and deformities that are similar to diabetic embryopathy. Proc Natl Acad Sci U S A (2003) 1.27
Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol Pharm (2005) 1.12
Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J Biol Chem (2002) 1.10
The peroxisome proliferator-activated receptor gamma agonist pioglitazone improves cardiometabolic risk and renal inflammation in murine lupus. J Immunol (2009) 1.06
Rosiglitazone treatment reduces diabetic neuropathy in streptozotocin-treated DBA/2J mice. Endocrinology (2008) 1.06
Diabetic nephropathy: of mice and men. Adv Chronic Kidney Dis (2005) 1.02
Role for GLUT1 in diabetic glomerulosclerosis. Expert Rev Mol Med (2006) 1.01
GLUT4 facilitative glucose transporter specifically and differentially contributes to agonist-induced vascular reactivity in mouse aorta. Arterioscler Thromb Vasc Biol (2005) 1.01
Identification of the glomerular podocyte as a target for growth hormone action. Endocrinology (2007) 0.94
GLUT1 enhances mTOR activity independently of TSC2 and AMPK. Am J Physiol Renal Physiol (2011) 0.93
Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice. Am J Physiol Renal Physiol (2010) 0.92
Induction of antioxidant enzymes in murine podocytes precedes injury by puromycin aminonucleoside. Kidney Int (2004) 0.92
A rapid, PPAR-gamma-dependent effect of pioglitazone on the phosphorylation of MYPT. Am J Physiol Cell Physiol (2009) 0.92
Evidence for a novel TGF-beta1-independent mechanism of fibronectin production in mesangial cells overexpressing glucose transporters. Diabetes (2003) 0.90
Effects of PPAR-gamma ligands on vascular smooth muscle marker expression in hypertensive and normal arteries. Am J Physiol Heart Circ Physiol (2004) 0.90
Glucose uptake and adenoviral mediated GLUT1 infection decrease hypoxia-induced HIF-1alpha levels in cardiac myocytes. J Mol Cell Cardiol (2002) 0.90
Hypoxia-inducible factor-1alpha is a critical mediator of hypoxia induced apoptosis in cardiac H9c2 and kidney epithelial HK-2 cells. BMC Cardiovasc Disord (2008) 0.87
Podocyte-specific GLUT4-deficient mice have fewer and larger podocytes and are protected from diabetic nephropathy. Diabetes (2013) 0.87
GLUT1-induced cFLIP expression promotes proliferation and prevents apoptosis in vascular smooth muscle cells. Am J Physiol Cell Physiol (2009) 0.86
The glomerular podocyte as a target of growth hormone action: implications for the pathogenesis of diabetic nephropathy. Curr Diabetes Rev (2011) 0.85
Perspectives on systems biology applications in diabetic kidney disease. J Cardiovasc Transl Res (2012) 0.84
Smooth muscle protein 22 alpha-Cre is expressed in myeloid cells in mice. Biochem Biophys Res Commun (2012) 0.84
Preserved expression of GLUT4 prevents enhanced agonist-induced vascular reactivity and MYPT1 phosphorylation in hypertensive mouse aorta. Am J Physiol Heart Circ Physiol (2007) 0.81
Podocyte specific knock out of selenoproteins does not enhance nephropathy in streptozotocin diabetic C57BL/6 mice. BMC Nephrol (2008) 0.81
GLUT1-deficient mice exhibit impaired endothelium-dependent vascular relaxation. Eur J Pharmacol (2004) 0.80
PI3-kinase-induced hyperreactivity in DOCA-salt hypertension is independent of GSK-3 activity. Hypertension (2003) 0.80
The management of diabetic neuropathy in CKD. Am J Kidney Dis (2009) 0.79
Increased JNK phosphorylation and oxidative stress in response to increased glucose flux through increased GLUT1 expression in rat retinal endothelial cells. Invest Ophthalmol Vis Sci (2005) 0.78
Is the ER stressed out in diabetic kidney disease? J Am Soc Nephrol (2008) 0.77
A new pair of SOCS for diabetic nephropathy. J Am Soc Nephrol (2010) 0.76
Do we now have a prognostic biomarker for progressive diabetic nephropathy? J Am Soc Nephrol (2012) 0.76
Increased vascular sensitivity and connexin43 expression after sympathetic denervation. Cardiovasc Res (2004) 0.76
How glucose and glucose transporters protect cardiac myocytes. J Mol Cell Cardiol (2003) 0.75